From the Health Services Research Program, Department of Neurology (C.C.L., B.C.C., J.F.B., L.E.S., C.E.H., K.A.K.), University of Michigan Medical School; Veterans Affairs Healthcare System (B.C.C., J.F.B., K.A.K.), Ann Arbor, MI; American Academy of Neurology (B.M., G.J.E.), Minneapolis, MN; and Department of Neurology (G.J.E.), School of Medicine, Emory University, Atlanta, GA.
Neurology. 2021 Jan 19;96(3):e309-e321. doi: 10.1212/WNL.0000000000011276. Epub 2020 Dec 23.
To describe geographic variation in neurologist density, neurologic conditions, and neurologist involvement in neurologic care.
We used 20% 2015 Medicare data to summarize variation by Hospital Referral Region (HRR). Neurologic care was defined as office-based evaluation/management visits with a primary diagnosis of a neurologic condition.
Mean density of neurologists varied nearly 4-fold from the lowest to the highest density quintile (9.7 [95% confidence interval (CI) 9.2-10.2] vs 43.1 [95% CI 37.6-48.5] per 100,000 Medicare beneficiaries). The mean prevalence of patients with neurologic conditions did not substantially differ across neurologist density quintile regions (293 vs 311 per 1,000 beneficiaries in the lowest vs highest quintiles, respectively). Of patients with a neurologic condition, 23.5% were seen by a neurologist, ranging from 20.6% in the lowest quintile regions to 27.0% in the highest quintile regions (6.4% absolute difference). Most of the difference comprised dementia, pain, and stroke conditions seen by neurologists. In contrast, very little of the difference comprised Parkinson disease and multiple sclerosis, both of which had a very high proportion (>80%) of neurologist involvement even in the lowest quintile regions.
The supply of neurologists varies substantially by region, but the prevalence of neurologic conditions does not. As neurologist supply increases, access to neurologist care for certain neurologic conditions (dementia, pain, and stroke) increases much more than for others (Parkinson disease and multiple sclerosis). These data provide insight for policy makers when considering strategies in matching the demand for neurologic care with the appropriate supply of neurologists.
描述神经科医生密度、神经科疾病以及神经科医生在神经科护理中的参与情况的地域差异。
我们使用了 2015 年 Medicare 数据的 20%,按医院转诊区(HRR)总结差异。神经科护理被定义为以神经科疾病为主要诊断的门诊评估/管理就诊。
神经科医生的平均密度从密度最低的五分位到密度最高的五分位相差近 4 倍(每 10 万 Medicare 受益人为 9.7 [95%置信区间(CI)9.2-10.2] vs 43.1 [95% CI 37.6-48.5])。患有神经科疾病的患者的平均患病率在神经科医生密度五分位区之间没有显著差异(分别为每 1000 名受益人为 293 名和 311 名)。在患有神经科疾病的患者中,有 23.5%由神经科医生就诊,从密度最低的五分位区的 20.6%到密度最高的五分位区的 27.0%(相差 6.4%)。差异主要由神经科医生就诊的痴呆、疼痛和中风疾病组成。相比之下,帕金森病和多发性硬化症的差异很小,这两种疾病的神经科医生参与率都非常高(>80%),即使在密度最低的五分位区也是如此。
神经科医生的供应在地域上存在很大差异,但神经科疾病的患病率并没有差异。随着神经科医生供应的增加,某些神经科疾病(痴呆、疼痛和中风)获得神经科护理的机会增加了很多,而其他疾病(帕金森病和多发性硬化症)则不然。这些数据为政策制定者在考虑将对神经科护理的需求与适当的神经科医生供应相匹配的策略时提供了参考。